ARIAD Pharmaceuticals Inc.

(NGS:ARIA) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Ariad Pharmaceuticals is a biotechnology company with a focus on cancer drugs. The global oncology company aims to discover, develop, and commercialize small-molecule medicines to treat aggressive cancers where current therapies are inadequate, including leukemia. The vast majority of Ariad's revenue is derived from its product revenue segment, followed by its license collaboration and other revenue segments. The United States represents a majority of the company? oncology profits based on roughly half of its global sales. Ariad seeks market share outside the U.S. through industry partnerships.

Contact Information

Website: www.ariad.com
Email: manmeet.soni@ariad.com
Main Phone: +1 617 494-0400
Address: 26 Landsdowne Street
State: MA
City / Town: Cambridge
Country: US
Postal Code: 02139-4234

Issuer Information

Exchange: NGS
CEO: Paris Panayiotopoulos
Employees: 459
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A